A carregar...
Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection
Immune checkpoint inhibitor (ICI) therapies have become the most important medical therapies in many malignancies, such as melanoma, non-small-cell lung cancer, and urogenital cancers. However, due to generally low response rates of PD-(L)1 monotherapy, both PD-(L)1 combination therapies and novel t...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7014370/ https://ncbi.nlm.nih.gov/pubmed/31952311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21020556 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|